Cargando…
Target product profile for a dengue pre-vaccination screening test
With increasing geographic spread, frequency, and magnitude of outbreaks, dengue continues to pose a major public health threat worldwide. Dengvaxia, a dengue live-attenuated tetravalent vaccine, was licensed in 2015, but post hoc analyses of long-term data showed serostatus-dependent vaccine perfor...
Autores principales: | Fongwen, Noah, Wilder-Smith, Annelise, Gubler, Duane J., Ooi, Eng Eong, T. Salvana, Edsel Maurice, de Lamballerie, Xavier, Olliaro, Piero L., Peeling, Rosanna W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320982/ https://www.ncbi.nlm.nih.gov/pubmed/34324505 http://dx.doi.org/10.1371/journal.pntd.0009557 |
Ejemplares similares
-
Optimising dengue pre-vaccination screening
por: Wilder-Smith, Annelies, et al.
Publicado: (2021) -
SARS-CoV-2 rapid antigen detection tests – Authors' reply
por: Peeling, Rosanna W, et al.
Publicado: (2021) -
Dengue Prevention and 35 Years of Vector Control in Singapore
por: Ooi, Eng-Eong, et al.
Publicado: (2006) -
Preventing Dengue Epidemics during the COVID-19 Pandemic
por: Wilder-Smith, Annelies, et al.
Publicado: (2020) -
Scaling up COVID-19 rapid antigen tests: promises and challenges
por: Peeling, Rosanna W, et al.
Publicado: (2021)